SDI Group plc (LSE:SDI) has reaffirmed its outlook for the 2027 financial year, saying it expects full-year results to be in line with current market expectations.
In a trading update issued ahead of its annual general meeting, the laboratory equipment and industrial and scientific products group reported organic growth alongside contributions from businesses acquired by the group.
SDI operates a buy-and-build strategy combining acquisitions with organic development across its existing portfolio.
Acquired Businesses Contribute to FY27 Trading
SDI said recently acquired businesses have contributed to trading during the early part of the financial year.
The company also reported organic growth across its operations as it entered FY27.
Based on trading to date, the group maintained its expectation that results for the full financial year will be in line with current market forecasts.
SDI Continues Buy-and-Build Strategy
SDI acquires and develops small and medium-sized businesses that manufacture specialist laboratory equipment, sensors and other industrial and scientific products.
The group operates a decentralised structure under which its portfolio companies retain operational autonomy while receiving financial and strategic support at group level.
SDI said it continues to consider potential acquisitions of complementary technology businesses, including companies with international operations.
Group Serves Industrial, Scientific and Medical Markets
SDI’s portfolio supplies products to a range of industrial, scientific and medical markets.
Its industrial end markets include aerospace, defence, semiconductors and precision manufacturing, while its scientific and medical operations serve areas including life sciences, healthcare and astronomy.
The group’s strategy combines the acquisition of specialist businesses with organic growth within its existing portfolio.
Leave a Reply